Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05616026 · ClinicalTrials.gov registry record · NA

Texts for Diabetes Control Among Homeless Persons

A NA study of Diabetes Mellitus, sponsored by George Washington University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT05616026 is a NA study of Diabetes Mellitus that is actively recruiting participants, run by George Washington University. The registered enrollment target is 100 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05616026, a NA study of Diabetes Mellitus, is actively recruiting participants, sponsored by George Washington University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control among persons who experience homelessness.

Conditions Studied

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Intervention

Study Locations (2)

District of Columbia

  • George Washington University - Washington D.C.

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-02-07
Est. Completion 2026-11-15
Phase NA

Sponsor

George Washington University

133 total trials

What the Registry Record Tells You About NCT05616026

The ClinicalTrials.gov registry entry for NCT05616026 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT05616026 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, New York.

Frequently Asked Questions

What is clinical trial NCT05616026 about?

NCT05616026 is a clinical study titled "Texts for Diabetes Control Among Homeless Persons". This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control among persons who experience homelessness.

What is the current status of trial NCT05616026?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-02-07. Estimated completion is 2026-11-15.

What conditions does trial NCT05616026 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT05616026?

The interventions under investigation include: Attention Control (BEHAVIORAL), Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05616026?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05616026 being conducted?

This trial has 2 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.